Skip to content

The application of three-dimensional reconstruction techniques in thoracoscopic segmental resection of the lung in early-stage non-small cell lung cancer

The application of three-dimensional reconstruction techniques in thoracoscopic segmental resection of the lung in early-stage non-small cell lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104962
Enrollment
Unknown
Registered
2025-06-26
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage Non-small Cell Lung Cancer

Interventions

3D reconstruction group (experimental group) :None
control group (plain chest CT):None

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–80 years, without major preoperative comorbidities. 2. Scheduled for thoracoscopic pulmonary segmentectomy. 3. Unilateral surgery (single-side procedure). 4. Availability of complete chest CT data with slice thickness <2 mm. 5. Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Poor-quality CT images due to patient movement or breathing during scanning. 2. Severe comorbidities (e.g., cardiac, hepatic, pulmonary, or renal insufficiency) rendering the patient unfit for surgery. 3. Lesions affecting pulmonary vasculature anatomy, such as: Pulmonary sequestration, Massive pneumothorax, Giant pulmonary bullae, Destroyed lung, Large hilar masses 4. History of chest trauma or ipsilateral thoracic surgery (risk of pleural adhesions). 5. Patients with psychiatric disorders. 6. Allergy to contrast agents or medical equipment used in the procedure.

Design outcomes

Primary

MeasureTime frame
Surgical duration;

Secondary

MeasureTime frame
Intraoperative subjective experience survey;Operative hemorrhage volume;Surgical adverse events;Postsurgical morbidity;Postsurgical hospitalization duration;Duration of postoperative chest tube drainage;Postoperative pleural drainage output;

Countries

China

Contacts

Public ContactXiaojun Du & Lihang Liao

The Affiliated Hospital of Guizhou Medical University

1017312905@qq.com+86 135 5116 5447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 23, 2026